Xeris Pharmaceuticals Receives US Patent for Its Novel, Stable Non-Aqueous …

Xeris Pharmaceuticals Receives US Patent for its Novel, Stable Non-Aqueous …
8,697,644, "Stable Formulations for Parenteral Injection of Peptide Drugs". The new … Currently, the standard of treatment for severe hypoglycemia requires the use of glucagon as a lyophilized powder which can be complex and burdensome, especially …
Read more on MarketWatch

Jim Allison confronts cancer, critics with immunotherapy
It was unfamiliar territory for the small-town boy from South Texas who had become a scientist and spent his research career on what many considered a lost cause, the study of the immune system's cancer-fighting potential. … of immunology at the …
Read more on SFGate

Related Drug Treatment Centers Austin Texas Information…